Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vortioxetine in Binge Eating Disorder
NCT02528409Phase 2Completed
- Sponsor
- University of Chicago
- Start
- Jun 2016
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vortioxetine in binge eating disorder (BED), sponsored by University of Chicago. Started Jun 2016; status: completed.
02
Drugs
vortioxetine
03
Conditions
binge eating disorder (BED)
Beyond the preview
Go deeper on NCT02528409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02528409.